Impact of dupilumab across seasons in patients with type 2 uncontrolled, moderate-to-severe asthma. Peters AT, Sagara H, Corren J, Domingo C, et al. Ann Allergy Asthma Immunol 2023 Nov 25:S1081-1206(23)01470.

Read + Share

Amedeo Smart

Independent Medical Education

Peters AT, Sagara H, Corren J, Domingo C, et al. Impact of dupilumab across seasons in patients with type 2 uncontrolled, moderate-to-severe asthma. Ann Allergy Asthma Immunol 2023 Nov 25:S1081-1206(23)01470.
PMID: 38013139